Amarin Corp Plc (AMRN)

[ziploc_1]

JR..."exclusive contracts that reduce competition may also violate the Sherman Antitrust Act and are subject to civil enforcement. "

The PBM's (pharmacy benefit managers) negotiate exclusive contracts with generic companies, which stipulate lower prices for the generic company's product...in return for the PBM refusing to list a competitor's product...

This common practice seems a clear violation of anti-trust laws...When Amarin eventually tries to list an AG( authorized generic) for Vascepa, Amarin's sole drug) with a PBM, this illegal practice of exclusivity will present a formidable challenge to Amarin....as opposed to generic companies that which have many products to list with a PBM.